EHA 2017 Congress Highlights in Multiple Myeloma


Efficacy of Ixazomib Maintenance in Myeloma Patients
Shaji K. Kumar, MD – Run Time: 4:40

Begin


Efficacy of Venetoclax in Patients with RRMM
Shaji Kumar, MD – Run Time: 5:14

Begin


Evaluating Long-term Prognosis in MM Patients: Lenalidomide, Maintenance and MRD
Philip L. McCarthy, MD – Run Time: 6:33

Begin


The Connect® MM Registry Trial: Results Across the Disease Spectrum
Philip L. McCarthy, MD – Run Time: 6:11

Begin


Denosumab for Bone Disease in NDMM
Noopur Raje, MD – Run Time: 2:54

Begin


IRd in Newly Diagnosed MM Patients
Noopur Raje, MD – Run Time: 3:34

Begin


First-in-Human Multicenter Trial of CAR-T Cells in RRMM Patients
Noopur Raje, MD – Run Time: 3:18

Begin


Efficacy of Daratumumab in RRMM: Two- vs Three-Drug Combinations and Cytogenetic Risk
Jesús San Miguel, MD – Run Time: 11:35

Begin